MaxCyte, Inc. (MXCT): A Bull Case Theory

We came across a bullish thesis on MaxCyte, Inc. (MXCT) on Substack by OppCost. In this article, we will summarize the bulls’ thesis on MXCT. MaxCyte, Inc. (MXCT)’s share was trading at $2.355 as of May 9th.

10 Best Biotech Stocks To Buy Under $20

A scientist in a lab conducting research on cell-based therapeutics and biotechnology.

MaxCyte, Inc. is a commercial-stage cell-engineering company with a strong strategic position in the rapidly growing cell and gene therapy (CGT) industry. The company’s core offering, the ExPERT™...